
About Benedic Pharmaceuticals
Benedic Pharmaceuticals is a company based in Haridwar (India) founded in 2016. It operates as a B2B. Benedic Pharmaceuticals operates in a competitive market with competitors including AmerisourceBergen, Entero Healthcare, Keimed, Sandor Medicaids and Mahaveer Medi Sales, among others.
- Headquarter Haridwar, India
- SectorsHealthcare
- Website benedicpharma.com
- Legal Name Benedic Pharmaceuticals Private Limited
- Date of Incorporation 14 Mar, 2016
- Jurisdiction Haridwar, Uttarakhand, India
- Annual Revenue₹2.81 Cr
FY 2025 · -1% YoY
- Net Profit₹14.2 Lakh
FY 2025 · 5% margin
- EBITDA₹48.3 Lakh
FY 2025 · 17% margin
Associated legal entities of Benedic Pharmaceuticals
Benedic Pharmaceuticals operates through Benedic Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Benedic Pharmaceuticals Private Limited CIN U51909UR2016PTC001952 | Active | 14 Mar 2016 | Haridwar, Uttarakhand | ₹2.8 Cr | – | 3 | View details |
Board of directors of Benedic Pharmaceuticals Private Limited (Benedic Pharmaceuticals)
Benedic Pharmaceuticals Private Limited is the primary company behind Benedic Pharmaceuticals. The board of Benedic Pharmaceuticals Private Limited currently have 3 directors; the longest-serving is Piyush Arora, appointed in 2016. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Piyush Arora DIN 07369279 | Director | 14 Mar 2016 | 10 yrs 6 mo | Benedic Pharmaceuticals Private Limited |
| Shantanu Virmani DIN 03562960 | Director | 14 Mar 2016 | 10 yrs 6 mo | Benedic Pharmaceuticals Private Limited |
| Indu Batra DIN 07369263 | Director | 14 Mar 2016 | 10 yrs 6 mo | Benedic Pharmaceuticals Private Limited |
Financials of Benedic Pharmaceuticals
Figures of Benedic Pharmaceuticals Private Limited, the primary company behind Benedic Pharmaceuticals, for FY 2025. Revenue was ₹2.81 Cr (-1% year on year). Net profit was ₹14.2 Lakh (5% margin). EBITDA was ₹48.3 Lakh (17% margin). Revenue has grown at a compounded annual rate of +4% over three years and +20% over five years.
- ₹2.81 CrRevenue · FY 2025 · -1% YoY
- ₹14.2 LakhNet profit · 5% margin
- ₹48.3 LakhEBITDA · 17% margin
- ₹12 LakhPaid-up capital
- +4%Revenue CAGR, 3 years
- +20%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Benedic Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Benedic Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Benedic Pharmaceuticals
Benedic Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AmerisourceBergen, Entero Healthcare, Keimed, Sandor Medicaids and Mahaveer Medi Sales, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| amerisourcebergen.com | 1985 | Chesterbrook, United States | – | 46,000 | Pharmaceutical distribution and supply chain services are provided globally. | |
| enterohealthcare.com | 2018 | Mumbai, India | $59.67M | 817 | India's leading healthcare products distribution platform | |
| keimed.com | 2000 | Hyderabad, India | $16.62M | 588 | Temperature-sensitive medicines are distributed via cold chain logistics by Keimed. | |
| sandor.co.in | 1995 | Hyderabad, India | $11.53M | 161 | Provider of medical equipment, devices, and drugs distribution services | |
| mahaveermedi.com | 2016 | Bengaluru, India | – | 588 | Serves as a distributor of a wide range of pharmaceutical drugs. | |
| dipnapharmachem.com | 2011 | Ahmedabad, India | – | – | Distributor of pharmaceutical raw materials |
Detailed competitors of Benedic Pharmaceuticals
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Benedic Pharmaceuticals
10 companies that operate in the same segment as Benedic Pharmaceuticals (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Benedic Pharmaceuticals
Benedic Pharmaceuticals was founded in 2016.
Benedic Pharmaceuticals is headquartered in Haridwar, India. It is registered at Haridwar, Uttarakhand, India.
The primary company behind Benedic Pharmaceuticals, Benedic Pharmaceuticals Private Limited, reported revenue of βΉ2.81 Cr for FY 2025, down 1% year on year.
Benedic Pharmaceuticals operates with a B2B model, focusing on providing healthcare solutions, producing pharmaceutical products, drug distribution, and wholesale. Serves as a distributor of a wide range of pharmaceutical drugs for healthcare providers. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
Benedic Pharmaceuticals's top competitors include Entero Healthcare, AmerisourceBergen and Keimed.
Benedic Pharmaceuticals operates through Benedic Pharmaceuticals Private Limited.
The legal entities of Benedic Pharmaceuticals currently have 3 directors, including Piyush Arora, Shantanu Virmani, Indu Batra.